The Tentamus Group announced the acquisition of BioMeca, a Lyon-based biotechnology company specializing in

Tentamus集团宣布收购位于里昂的生物技术公司BioMeca，该公司专注于

biomechanics

生物力学

and

和

mechanobiology

机械生物学

. This strategic acquisition further expands Tentamus’ expertise in the life sciences sector, particularly in the high-resolution structural and mechanical characterization of biological samples, including tissues, cells, DNA, and proteins.

此次战略性收购进一步拓展了Tentamus在生命科学领域的专业能力，尤其是在生物样本（包括组织、细胞、DNA和蛋白质）的高分辨率结构与机械特性表征方面。

BioMeca is renowned for its innovative use of Atomic Force Microscopy (AFM) and advanced imaging techniques to provide tailored solutions for health and well-being, supporting industries such as cosmetics and pharmaceuticals. By integrating BioMeca’s cutting-edge technologies and deep expertise, Tentamus will enhance its ability to deliver comprehensive, high-value services to clients worldwide, while maintaining a strong local presence in France..

BioMeca 以其创新性地运用原子力显微镜（AFM）和先进成像技术而闻名，为健康和福祉领域提供定制化解决方案，服务于化妆品和制药等行业。通过整合 BioMeca 的前沿技术和深厚专业知识，Tentamus 将增强其向全球客户提供全面、高价值服务的能力，同时在法国保持强大的本地存在感。

Dr. Christian Rebhan, CEO of Tentamus Group, commented: 'The acquisition of BioMeca is a significant milestone in our mission to provide best-in-class analytical and consulting services. BioMeca’s expertise in biomechanics and surface analysis perfectly complements our existing capabilities, allowing us to offer even more specialized and innovative solutions to our clients in life sciences and beyond.

Tentamus集团首席执行官Christian Rebhan博士表示：“收购BioMeca是我们在提供顶级分析和咨询服务使命中的一个重要里程碑。BioMeca在生物力学和表面分析方面的专业知识与我们现有的能力完美互补，使我们能够为生命科学及其他领域的客户提供更加专业和创新解决方案。”

We are excited to welcome the BioMeca team to the Tentamus family and look forward to the synergies this partnership will create.'.

我们很高兴欢迎 BioMeca 团队加入 Tentamus 大家庭，并期待此次合作将产生的协同效应。

“Joining Tentamus Group marks an exciting new chapter for BioMeca,” said Julien Chlasta and Gaël Runel, CEO and Founder of BioMeca and R&D Director, respectively. “This partnership will allow us to scale our impact, invest in new technologies, and better serve our clients with the backing of a global leader in laboratory services.”.

“加入Tentamus集团标志着BioMeca开启了一个令人振奋的新篇章，”BioMeca的首席执行官兼创始人Julien Chlasta以及研发总监Gaël Runel表示。“此次合作将使我们能够扩大影响力，投资新技术，并在全球实验室服务领导者的支持下更好地服务我们的客户。”

This acquisition aligns with Tentamus’ ongoing growth strategy, which focuses on expanding its global network of specialized laboratories and strengthening its position as a trusted partner for industries requiring advanced analytical and regulatory support.

此次收购符合 Tentamus 的持续增长战略，该战略侧重于扩大其全球专业实验室网络，并巩固其作为需要先进分析和监管支持的行业可信赖合作伙伴的地位。

https://www.bionity.com/en/news/1189016/tentamus-acquires-biomeca-and-strengthens-its-life-sciences-portfolio.html

https://www.bionity.com/en/news/1189016/tentamus-acquires-biomeca-and-strengthens-its-life-sciences-portfolio.html

Danaher to Acquire Abcam

丹纳赫将收购Abcam

Read news

阅读新闻

Most read news

阅读最多的新闻

1

1

It may not just be what’s in ultra-processed foods, but how they’re made

问题可能不仅在于超加工食品中的成分，还在于其制作方式

2

2

New drug could slow the development of Alzheimer’s

新药或可延缓阿尔茨海默病的发展

3

3

Cytospire Therapeutics announces oversubscribed £61 million Series A financing

Cytospire Therapeutics 宣布超额认购的6100万英镑A轮融资

4

4

New antibiotics discovered to treat multi-resistant germs

发现新型抗生素以治疗多重耐药菌

5

5

Egg consumption is associated with a lower risk of Alzheimer’s Disease

食用鸡蛋与降低阿尔茨海默病风险相关

Topics

主题

aquisition

收购

biomechanics

生物力学

mechanobiology

机械生物学

atomic force microscopy

原子力显微镜

imaging

成像

surface analytics

表面分析

life science

生命科学

laboratory service

实验室服务

Show all

显示全部

Show less

显示更少

Organizations

组织

Tentamus

我们尝试